Published in Eur J Biochem on November 01, 2001
Expression quantitative trait Loci for extreme host response to influenza a in pre-collaborative cross mice. G3 (Bethesda) (2012) 1.35
Transcription factor redundancy ensures induction of the antiviral state. J Biol Chem (2010) 1.32
Identification of a novel gene family that includes the interferon-inducible human genes 6-16 and ISG12. BMC Genomics (2004) 1.04
Whole blood gene expression in infants with respiratory syncytial virus bronchiolitis. BMC Infect Dis (2006) 0.97
ISG12 is a critical modulator of innate immune responses in murine models of sepsis. Immunobiology (2013) 0.89
Interferons as inducers of apoptosis in malignant cells. J Interferon Cytokine Res (2013) 0.87
The Interferon-Stimulated Gene Ifi27l2a Restricts West Nile Virus Infection and Pathogenesis in a Cell-Type- and Region-Specific Manner. J Virol (2015) 0.79
Gene Expression Profile of High IFN-γ Producers Stimulated with Leishmania braziliensis Identifies Genes Associated with Cutaneous Leishmaniasis. PLoS Negl Trop Dis (2016) 0.75
Class-1 translation termination factors: invariant GGQ minidomain is essential for release activity and ribosome binding but not for stop codon recognition. Nucleic Acids Res (2001) 1.94
Cloning the spoT gene of Escherichia coli: identification of the spoT gene product. J Bacteriol (1979) 1.73
Diadenosine oligophosphates (Ap(n)A), a novel class of signalling molecules? FEBS Lett (1998) 1.59
A prospective study of glomerular filtration rate and arterial blood pressure in insulin-dependent diabetics with diabetic nephropathy. Diabetologia (1981) 1.53
pyrR identical to pyrH in Salmonella typhimurium: control of expression of the pyr genes. J Bacteriol (1975) 1.49
Functional expression of eukaryotic polypeptide chain release factors 1 and 3 by means of baculovirus/insect cells and complex formation between the factors. Eur J Biochem (1998) 1.45
Number and proliferative capacity of osteogenic stem cells are maintained during aging and in patients with osteoporosis. J Bone Miner Res (2001) 1.39
Troglitazone treatment increases bone marrow adipose tissue volume but does not affect trabecular bone volume in mice. Calcif Tissue Int (2001) 1.32
Human interferon gamma potently induces the synthesis of a 55-kDa protein (gamma 2) highly homologous to rabbit peptide chain release factor and bovine tryptophanyl-tRNA synthetase. Proc Natl Acad Sci U S A (1991) 1.21
A major loss in islet mass and B-cell function precedes hyperglycemia in mice given multiple low doses of streptozotocin. Diabetes (1981) 1.19
Differential regulation of the human, interferon inducible tryptophanyl-tRNA synthetase by various cytokines in cell lines. Cytokine (1995) 1.19
Expression of CD44 in human lung tumors. Cancer Res (1994) 1.18
p59OASL, a 2'-5' oligoadenylate synthetase like protein: a novel human gene related to the 2'-5' oligoadenylate synthetase family. Nucleic Acids Res (1998) 1.17
Transcriptional regulation of the interferon-gamma-inducible tryptophanyl-tRNA synthetase includes alternative splicing. J Biol Chem (1995) 1.14
CD44 expression in colorectal adenomas is an early event occurring prior to K-ras and p53 gene mutation. Arch Biochem Biophys (1994) 1.13
Mutational screening and association study of glutamate decarboxylase 1 as a candidate susceptibility gene for bipolar affective disorder and schizophrenia. Am J Med Genet B Neuropsychiatr Genet (2005) 1.11
Mapping and identification of interferon gamma-regulated HeLa cell proteins separated by immobilized pH gradient two-dimensional gel electrophoresis. Electrophoresis (1999) 1.09
Expression of the heat-shock protein HSP70 in Drosophila buzzatii lines selected for thermal resistance. Hereditas (1999) 1.06
Activation of 2'-5' oligoadenylate synthetase by single-stranded and double-stranded RNA aptamers. J Biol Chem (1998) 1.02
The human umbilical cord blood: a potential source for osteoblast progenitor cells. Calcif Tissue Int (2002) 1.01
Perivascular T cells express the pro-inflammatory chemokine RANTES mRNA in multiple sclerosis lesions. Scand J Immunol (1997) 0.98
Sensitive and fast mutation detection by solid phase chemical cleavage. Hum Mutat (1996) 0.98
Interleukin-20 plays a critical role in maintenance and development of psoriasis in the human xenograft transplantation model. Br J Dermatol (2008) 0.98
The antiviral 2',5'-oligoadenylate synthetase is persistently activated in type 1 diabetes. Clin Immunol (2000) 0.96
Identification and characterization of human mitochondrial tryptophanyl-tRNA synthetase. J Biol Chem (2000) 0.95
[Identification of a novel termination release factor eRF3b expressing the eRF3 activity in vitro and in vivo]. Mol Biol (Mosk) (2001) 0.95
Are the tryptophanyl-tRNA synthetase and the peptide-chain-release factor from higher eukaryotes one and the same protein? Eur J Biochem (1993) 0.94
Mammalian polypeptide chain release factor and tryptophanyl-tRNA synthetase are distinct proteins. EMBO J (1993) 0.94
Alternative processing of the tryptophanyl-tRNA synthetase mRNA from interferon-treated human cells. Eur J Biochem (1996) 0.94
2'5' oligoadenylate synthetase, an interferon induced enzyme: direct assay methods for the products, 2'5' oligoadenylates and 2'5' co-oligonucleotides. Nucleic Acids Res (1980) 0.92
Gene structure of the murine 2'-5'-oligoadenylate synthetase family. Cell Mol Life Sci (2002) 0.92
The 2'5' oligoadenylate synthetase has a multifunctional 2'5' nucleotidyl-transferase activity. Biochem Biophys Res Commun (1981) 0.92
Cytokines and bone loss in a 5-year longitudinal study--hormone replacement therapy suppresses serum soluble interleukin-6 receptor and increases interleukin-1-receptor antagonist: the Danish Osteoporosis Prevention Study. J Bone Miner Res (2000) 0.91
A trial of metoprolol in hypertensive insulin-dependent diabetic patients. Acta Med Scand (1982) 0.89
Pancreatic islet volume distribution: direct measurement in preparations stained by perfusion in situ. Acta Endocrinol (Copenh) (1984) 0.88
Elongation mechanism and substrate specificity of 2',5'-oligoadenylate synthetase. Proc Natl Acad Sci U S A (1980) 0.88
Aged human bone marrow stromal cells maintaining bone forming capacity in vivo evaluated using an improved method of visualization. Biogerontology (2004) 0.86
The physiology of stringent factor (ATP:GTP 3'-diphosphotransferase) in Escherichia coli. Biochimie (1986) 0.85
Relationship between CD44 expression and cell proliferation in epithelium and stroma of colorectal neoplasms. Am J Pathol (1996) 0.85
The interferon-induced gene ISG12 is regulated by various cytokines as the gene 6-16 in human cell lines. Cytokine (2000) 0.85
Glucagon receptors on isolated hepatocytes and hepatocyte membrane vesicles. Discrete populations with ligand- and environment-dependent affinities. J Biol Chem (1983) 0.83
Gene dosage and down-regulation of the alpha-interferon receptor. Scand J Clin Lab Invest (1992) 0.83
Increased concentration of the fast-acting plasminogen activator inhibitor in plasma associated with familial venous thrombosis. Br J Haematol (1987) 0.83
Refocusing of B-cell responses following a single amino acid substitution in an antigen. Immunology (2001) 0.83
Surface receptors for pancreatic hormones in dog and rat hepatocytes: qualitative and quantitative differences in hormone-target cell interactions. Proc Natl Acad Sci U S A (1982) 0.83
Cell volume increase in murine MC3T3-E1 pre-osteoblasts attaching onto biocompatible tantalum observed by magnetic AC mode atomic force microscopy. Eur Cell Mater (2005) 0.83
(2'-5') Oligoadenylate synthetase in the maturation of rabbit reticulocytes. Mol Cell Biochem (1984) 0.82
Active recombinant rat dipeptidyl aminopeptidase I (cathepsin C) produced using the baculovirus expression system. Protein Expr Purif (1998) 0.82
Conformational changes of the reactive-centre loop and beta-strand 5A accompany temperature-dependent inhibitor-substrate transition of plasminogen-activator inhibitor 1. Eur J Biochem (1996) 0.82
Structural requirements of (2'-5') oligoadenylate for protein synthesis inhibition in human fibroblasts. Nucleic Acids Res (1982) 0.81
Hidradenitis suppurativa: a disease of the absent sebaceous gland? Sebaceous gland number and volume are significantly reduced in uninvolved hair follicles from patients with hidradenitis suppurativa. Br J Dermatol (2011) 0.81
Suppression of eukaryotic translation termination by selected RNAs. RNA (2000) 0.81
Different effects of high glucose and high fat diet on pancreatic insulin and glucagon in female and male mice. Diabete Metab (1982) 0.80
Evidence for a locus (IDDM16) in the immunoglobulin heavy chain region on chromosome 14q32.3 producing susceptibility to type 1 diabetes. Genes Immun (2002) 0.80
Dimethylfumarate inhibits MIF-induced proliferation of keratinocytes by inhibiting MSK1 and RSK1 activation and by inducing nuclear p-c-Jun (S63) and p-p53 (S15) expression. Inflamm Res (2011) 0.80
Effects of the natural and artificial menstrual cycle on the production of osteoprotegerin and the bone resorptive cytokines IL-1beta and IL-6. Calcif Tissue Int (2002) 0.80
beta-Cell function relative to islet volume and hormone content in the isolated perfused mouse pancreas. Endocrinology (1983) 0.80
A sensitive assay of translational fidelity (readthrough and termination) in eukaryotic cells. Biochemistry (Mosc) (1999) 0.80
Selective degradation of 2'-adenylated diadenosine tri- and tetraphosphates, Ap(3)A and Ap(4)A, by two specific human dinucleoside polyphosphate hydrolases. Arch Biochem Biophys (2000) 0.79
Two inducers of cell differentiation enhance the 2'5' oligoadenylate synthetase activity in MSV transformed cells. Biochem Biophys Res Commun (1981) 0.79
Regulation of 2-5 A synthetase activity and antiviral state in interferon treated chick cells. Biochem Biophys Res Commun (1982) 0.79
Synergistic effects of HuIFN-gamma on 2',5'-oligoadenylate synthetase induction by HuIFN-alpha. J Interferon Res (1986) 0.78
Genetically determined difference in the antiviral action of alpha/beta interferon in cells from mice resistant or susceptible to herpes simplex virus type 2. J Gen Virol (1986) 0.78
Murine pancreatic beta TC3 cells show greater 2', 5'-oligoadenylate synthetase (2'5'AS) antiviral enzyme activity and apoptosis following IFN-alpha or poly(I:C) treatment than pancreatic alpha TC3 cells. Exp Diabetes Res (2009) 0.78
Interferon induction, 2'-5' oligo A synthetase and lymphocyte subpopulations in out-patients with multiple sclerosis in a longitudinal study. Acta Neurol Scand (1986) 0.78
Topical valrubicin application reduces skin inflammation in murine models. Br J Dermatol (2012) 0.77
Effect of increased gene dosage expression on the alpha-interferon receptors in Down's syndrome. Biochim Biophys Acta (1993) 0.77
Induced and down-regulated proteins in the human cultured hairy cell leukemia line JOK-1 and the Burkitt's lymphoma cell line Daudi during incubation with interferon-alpha: a kinetic study. J Interferon Res (1992) 0.77
The natural course of glomerular filtration rate and arterial blood pressure in diabetic nephropathy, and the effect of antihypertensive treatment. Acta Endocrinol Suppl (Copenh) (1981) 0.77
Assignment of the human peptide chain release factor 3 (GSPT2) to Xp11.23-->p11.21 and of the distal marker DXS1039 by radiation hybrid mapping. Cytogenet Cell Genet (1999) 0.77
Tolerability of interferon alpha-2b, a possible new treatment of active Crohn's disease. Aliment Pharmacol Ther (1995) 0.76
Specific inhibitors prevent proteolytic degradation of recombinant proteins expressed in High Five cells. Biotechniques (2001) 0.76
Increased IFN-alpha-induced sensitivity but reduced reactivity of 2',5'-oligoadenylate synthetase (2,5AS) in trisomy 21 blood lymphocytes. Clin Exp Immunol (1993) 0.76
Effects of fasting on beta-cell function, body fat, islet volume, and total pancreatic insulin content. Metabolism (1984) 0.76
IFN-induced modulation of histocompatibility antigens on human cells. Background, mechanisms and perspectives. Cancer Metastasis Rev (1988) 0.76
Assignment of the human mitochondrial tryptophanyl-tRNA synthetase (WARS2) to 1p13.3-->p13.1 by radiation hybrid mapping. Cytogenet Cell Genet (1998) 0.76
Stereological estimation of epidermal volumes and dermo-epidermal surface area in normal skin. Dermatology (2011) 0.76
Assignment of the human postmeiotic segregation increased (S. cerevisiae) 1 (PMS1) to chromosome 2q31.1 by radiation hybrid mapping. Cytogenet Cell Genet (2000) 0.75
The endocrine pancreas aspects of beta-cell function in relation to morphology, insulin secretion and insulin content. Scand J Clin Lab Invest Suppl (1986) 0.75
2'-adenylated derivatives of Ap3A activate RNase L. FEBS Lett (1999) 0.75
Separate estimation of biological and analytical variance components when quantities and reagents are unstable. Scand J Clin Lab Invest (1995) 0.75
Evidence for the viral aetiology of IDDM. Autoimmunity (1997) 0.75
IgE in atopic dermatitis: a study of the intercellular fluid. Acta Derm Venereol (1987) 0.75
Assignment of human NADH dehydrogenase (ubiquinone) 1 beta subcomplex 3 (NDUFB3) and of its four pseudogenes to human chromosomes 2q31.3, 1p13.3-->p13.1, 9q32-->q34.1, 14q22.3-->q23.1 and 14q32.2 by radiation hybrid mapping. Cytogenet Cell Genet (2001) 0.75
2-5A synthetase activities in herpes virus infection and after interferon treatment. Adv Exp Med Biol (1986) 0.75
Acute platelet activation induced by smoking cigarettes: in vivo and ex vivo studies in humans. Adv Exp Med Biol (1990) 0.75
[Current therapeutic targeting possibilities in leukemia]. Nord Med (1991) 0.75
Immunological recovery and dose evaluation in IFN-alpha treatment of hairy cell leukemia: analysis of leukocyte differentiation antigens, NK and 2',5'-oligoadenylate synthetase activity. Eur J Haematol (1989) 0.75
Inhibition of mouse fibroblast interferon by gangliosides. Differential effects on biological activity and on induction of (2'--5')oligoadenylate synthetase. Eur J Biochem (1982) 0.75
An H-2 alloantiserum preserves beta-cell function in mice made diabetic by low-dose streptozocin. Diabetes (1986) 0.75
Search for a retrovirus in long-term cultured cerebrospinal fluid cells and peripheral blood mononuclear cells from patients with multiple sclerosis. Acta Neurol Scand (1989) 0.75
Assignment of the human mitochondrial translational release factor 1 (MTRF1) to chromosome 13q14.1-->q14.3 and of the human mitochondrial ribosome recycling factor (MRRF) to chromosome 9q32-->q34.1 with radiation hybrid mapping. Cytogenet Cell Genet (2000) 0.75
Inhibition of 2'-5' oligoadenylate synthetase by divalent metal ions. FEBS Lett (2001) 0.75
The interferon/2-5A synthetase system in primary preleukaemia patients. Prog Clin Biol Res (1985) 0.75